About Provell Pharmaceuticals
Provell Pharmaceuticals is a private company based in Honey Brook, Pennsylvania. It has reported $12,600,000 raised in six offerings on Form D since December 2013.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 31, 2024 | Feb 14, 2024 | $600,000fully sold | 1 | $600K | Debt, Options, Convertible Note that converts into membership interest of Issuer in accordance with the terms therein.Rule 506(b) | Form D ↗ |
| Aug 1, 2023 | Aug 15, 2023 | $1,000,000fully sold | 1 | $1.0M | Debt, Options, Convertible Note that converts into membership interest of Issuer in accordance with the terms therein.Rule 506(b) | Form D ↗ |
| Mar 15, 2023 | Mar 28, 2023 | $2,000,000fully sold | 1 | $2.0M | EquityRule 506(b) | Form D ↗ |
| Jun 29, 2022 | Jul 11, 2022 | $2,000,000fully sold | 1 | $2.0M | EquityRule 506(b) | Form D ↗ |
| Jun 25, 2019 | Jul 10, 2019 | $2,000,000fully sold | 1 | $2.0M | EquityRule 506(b) | Form D ↗ |
| Oct 3, 2013 | Dec 3, 2013 | $5,000,000fully sold | 1 | $5.0M | EquityRule 506(b) | Form D ↗ |
| Total, six offerings | $12,600,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Provell Pharmaceuticals's Form D filed Feb 14, 2024.
JS
James Small
Executive officer